Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents
Natural products have served humanity as a valuable source for the discovery and development of therapeutic agents. In addition, these phytochemicals can function as lead compounds for the development of synthetic analogs aimed at treating human diseases. In our aging society, Alzheimer’s disease (A...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2020-12-01
|
| Series: | Biomolecular Concepts |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/bmc-2020-0018 |
| id |
doaj-8b1043361df041f88cc0df6877ffa184 |
|---|---|
| record_format |
Article |
| spelling |
doaj-8b1043361df041f88cc0df6877ffa1842021-09-05T20:42:36ZengDe GruyterBiomolecular Concepts1868-50211868-503X2020-12-0111120120810.1515/bmc-2020-0018bmc-2020-0018Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agentsTsarbopoulos Anthony0National and Kapodistrian University of Athens Medical School, Department of Pharmacology, Athens, Greece, Athens 11527, GreeceNatural products have served humanity as a valuable source for the discovery and development of therapeutic agents. In addition, these phytochemicals can function as lead compounds for the development of synthetic analogs aimed at treating human diseases. In our aging society, Alzheimer’s disease (AD) is the most common cause of dementia, which is characterized by a significant and progressive loss of memory and other cognitive functions. As society demographics change, the predominance of AD and other age-related dementias is increasing, with concurrent financial and societal costs.https://doi.org/10.1515/bmc-2020-0018alzheimer’s diseasenatural productsamyloidogenesisprotein aggregation inhibitorscrocus sativus l |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Tsarbopoulos Anthony |
| spellingShingle |
Tsarbopoulos Anthony Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents Biomolecular Concepts alzheimer’s disease natural products amyloidogenesis protein aggregation inhibitors crocus sativus l |
| author_facet |
Tsarbopoulos Anthony |
| author_sort |
Tsarbopoulos Anthony |
| title |
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents |
| title_short |
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents |
| title_full |
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents |
| title_fullStr |
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents |
| title_full_unstemmed |
Alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents |
| title_sort |
alzheimer‘s disease: exploring nature’s ‘medicinal chest’ for new therapeutic agents |
| publisher |
De Gruyter |
| series |
Biomolecular Concepts |
| issn |
1868-5021 1868-503X |
| publishDate |
2020-12-01 |
| description |
Natural products have served humanity as a valuable source for the discovery and development of therapeutic agents. In addition, these phytochemicals can function as lead compounds for the development of synthetic analogs aimed at treating human diseases. In our aging society, Alzheimer’s disease (AD) is the most common cause of dementia, which is characterized by a significant and progressive loss of memory and other cognitive functions. As society demographics change, the predominance of AD and other age-related dementias is increasing, with concurrent financial and societal costs. |
| topic |
alzheimer’s disease natural products amyloidogenesis protein aggregation inhibitors crocus sativus l |
| url |
https://doi.org/10.1515/bmc-2020-0018 |
| work_keys_str_mv |
AT tsarbopoulosanthony alzheimersdiseaseexploringnaturesmedicinalchestfornewtherapeuticagents |
| _version_ |
1717785408446660608 |